{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:13:33Z","timestamp":1789794813980,"version":"4.0.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Increases in fatal drug poisonings and hepatitis C infections associated with the opioid epidemic are relatively well defined, because passive surveillance systems for these conditions exist. Less described is the association between the opioid epidemic and skin, soft-tissue, and venous infections (SSTVIs), endocarditis, sepsis, and osteomyelitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Michigan hospitalizations between 2016 and 2018 that included an International Classification of Diseases, Tenth Revision, Clinical Modification, code indicating substance use were examined for codes indicative of infectious conditions associated with injecting drugs. Trends in these hospitalizations were examined, as were demographic characteristics, discharge disposition, payer, and cost data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among hospitalized patients with a substance use diagnosis code, endocarditis, osteomyelitis, sepsis, and SSTVI hospitalizations increased by 33%, 35%, 24%, and 12%, respectively between 2016 and 2018. During this time frame, 1257 patients died or were discharged to hospice. All SSTVI hospitalizations resulted in &amp;gt;$1.3 billion in healthcare costs. Public insurance accounted for more than two-thirds of all hospitalization costs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study describes a method for performing surveillance for infection-related sequelae of injection drug use. Endocarditis, osteomyelitis, sepsis, and SSTVI hospitalizations have increased year over year between 2016 and 2018. These hospitalizations result in significant morbidity, mortality, and healthcare costs and should be a focus of future surveillance and prevention efforts.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaa012","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T20:08:53Z","timestamp":1579118933000},"page":"S451-S457","source":"Crossref","is-referenced-by-count":32,"title":["Trends in Morbidity, Mortality, and Cost of Hospitalizations Associated With Infectious Disease Sequelae of the Opioid Epidemic"],"prefix":"10.1093","volume":"222","author":[{"given":"Joseph R","family":"Coyle","sequence":"first","affiliation":[{"name":"Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health, Communicable Disease Division, Lansing, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Freeland","sequence":"additional","affiliation":[{"name":"Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health, Communicable Disease Division, Lansing, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth T","family":"Eckel","sequence":"additional","affiliation":[{"name":"Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health, Communicable Disease Division, Lansing, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L","family":"Hart","sequence":"additional","affiliation":[{"name":"Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health, Communicable Disease Division, Lansing, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"2020090213231625800_CIT0001","volume-title":"CDC WONDER","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"2020090213231625800_CIT0002","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2105\/AJPH.2017.304265","article-title":"Quantifying the epidemic of prescription opioid overdose deaths","volume":"108","author":"Seth","year":"2018","journal-title":"Am J Public Health"},{"key":"2020090213231625800_CIT0003","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020090213231625800_CIT0004","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths\u201427 states, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020090213231625800_CIT0005","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002-12","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"2020090213231625800_CIT0006","doi-asserted-by":"crossref","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs","volume":"3","author":"Wurcel","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2020090213231625800_CIT0007","doi-asserted-by":"crossref","first-page":"569","DOI":"10.15585\/mmwr.mm6622a1","article-title":"Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence\u2014North Carolina, 2010\u20132015","volume":"66","author":"Fleischauer","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020090213231625800_CIT0008","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archderm.143.10.1305","article-title":"Injection drug use: an understudied cause of venous disease","volume":"143","author":"Pieper","year":"2007","journal-title":"Arch Dermatol"},{"key":"2020090213231625800_CIT0009","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1001\/archinte.167.16.1807-a","article-title":"Chronic venous disease and injection drug use","volume":"167","author":"Pieper","year":"2007","journal-title":"Arch Intern Med"},{"key":"2020090213231625800_CIT0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am J Public Health"},{"key":"2020090213231625800_CIT0011","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020090213231625800_CIT0012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15585\/mmwr.mm6503a2","article-title":"Increases in acute hepatitis B virus infections\u2014Kentucky, Tennessee, and West Virginia, 2006\u20132013","volume":"65","author":"Harris","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020090213231625800_CIT0013","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","article-title":"County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States","volume":"73","author":"Van Handel","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020090213231625800_CIT0014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"N Engl J Med"},{"key":"2020090213231625800_CIT0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm6453a1","article-title":"Summary of notifiable infectious diseases and conditions\u2014United States, 2015","volume":"64","author":"Adams","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020090213231625800_CIT0016","author":"Centers for Disease Control and Prevention"},{"key":"2020090213231625800_CIT0017","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3201\/eid2308.170439","article-title":"Opiate injection-associated skin, soft tissue, and vascular infections, England, UK, 1997\u20132016","volume":"23","author":"Lewer","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2020090213231625800_CIT0018","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jinf.2012.10.004","article-title":"Needles and the damage done: reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital","volume":"66","author":"Marks","year":"2013","journal-title":"J Infect"},{"key":"2020090213231625800_CIT0019","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMra042823","article-title":"Bacterial infections in drug users","volume":"353","author":"Gordon","year":"2005","journal-title":"N Engl J Med"},{"key":"2020090213231625800_CIT0020","first-page":"e3521","article-title":"The impact of the drug epidemic on the incidence of sepsis in West Virginia","volume":"10","author":"Annie","year":"2018","journal-title":"Cureus"},{"key":"2020090213231625800_CIT0021","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0033354916670871","article-title":"The promise of electronic case reporting","volume":"131","author":"Mac Kenzie","year":"2016","journal-title":"Public Health Rep"},{"key":"2020090213231625800_CIT0022","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"2020090213231625800_CIT0023","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis","volume":"43","author":"Aspinall","year":"2014","journal-title":"Int J Epidemiol"},{"key":"2020090213231625800_CIT0024","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-017-0156-z","article-title":"Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis","volume":"14","author":"Davis","year":"2017","journal-title":"Harm Reduct J"},{"key":"2020090213231625800_CIT0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.epidem.2019.02.003","article-title":"Hepatitis C transmission in young people who inject drugs: Insights using a dynamic model informed by state public health surveillance","volume":"27","author":"Gicquelais","year":"2019","journal-title":"Epidemics"},{"key":"2020090213231625800_CIT0026","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/cid\/cit296","article-title":"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy","volume":"57","author":"Martin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020090213231625800_CIT0027","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2105\/AJPH.85.11.1531","article-title":"Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program","volume":"85","author":"Hagan","year":"1995","journal-title":"Am J Public Health"},{"key":"2020090213231625800_CIT0028","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08897077.2016.1263592","article-title":"Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: A community-based observational study","volume":"38","author":"Dahlman","year":"2017","journal-title":"Subst Abus"},{"key":"2020090213231625800_CIT0029","author":"Harm Reduction Coalition"},{"key":"2020090213231625800_CIT0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0740-5472(00)00104-5","article-title":"Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors","volume":"19","author":"Hagan","year":"2000","journal-title":"J Subst Abuse Treat"},{"key":"2020090213231625800_CIT0031","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/clc.23162","article-title":"Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact","volume":"42","author":"Bates","year":"2019","journal-title":"Clin Cardiol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_5\/S451\/33708083\/jiaa012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_5\/S451\/33708083\/jiaa012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:12:51Z","timestamp":1599073971000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/222\/Supplement_5\/S451\/5900597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":31,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2020,9,2]]},"published-print":{"date-parts":[[2020,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa012","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10,1]]},"published":{"date-parts":[[2020,9,2]]}}}